Skip to main content
Top

Drugs

Issue 1/2024

Content (12 Articles)

Open Access Generalized Pustular Psoriasis Review Article

Spesolimab for the Treatment of Generalized Pustular Psoriasis

Diana Bernardo, Diamant Thaçi, Tiago Torres

Open Access Systematic Review

Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis

Nikolaos Christidis, Essam Ahmed Al-Moraissi, Golnaz Barjandi, Johanna Svedenlöf, Hajer Jasim, Maria Christidis, Malin Collin

Open Access Timolol Original Research Article

Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension

John P. Berdahl, Steven R. Sarkisian Jr, Robert E. Ang, Long V. Doan, Angela C. Kothe, Dale W. Usner, L. Jay Katz, Tomas Navratil, Robert E. T. Ang, Jason Bacharach, Harmohina Bagga, Kent P. Bashford, John P. Berdahl, Yun-Sen Ralph Chu, Robert J. Cionni, Charles J. Crane, Francis A. D’Ambrosio, Mohammed K. ElMallah, Raj K. Goyal, Jason J. Jones, Joshua W. Kim, Robert P. Lehmann, Christopher Lin, David M. Lubeck, Robert E. Marquis, Cathleen M. McCabe, George R. Reiss, Steven R. Sarkisian Jr., Robert C. Sorenson, Farrell C. Tyson II, Steven D. Vold, Charles H. Weber , Bin Wu, David E. Yomtoob

Open Access Myasthenia Gravis AdisInsight Report

Zilucoplan: First Approval

Matt Shirley

Osteoporosis AdisInsight Report

Narlumosbart: First Approval

Sohita Dhillon

Human Papillomavirus Letter to the Editor

Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”

Thomas Yen-Ting Chen, Qianru Zhang, Yao-Min Hung, Renin Chang, Shiow-Ing Wang, James Cheng-Chung Wei